Aue, G., Lindorfer, M. A., Beum, P. V., Pawluczkowycz, A. W., Vire, B., Hughes, T., Taylor, R. P. and Wiestner, A. (2010) “Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia”, Haematologica. Pavia, Italy, 95(2), pp. 329-332. doi: 10.3324/haematol.2009.012484.